ROBOSENSE(02498)
Search documents
港股机器人概念股集体上涨,越疆(02432.HK)上涨18%,速腾聚创(02498.HK)涨超9%,优必选(09880.HK)涨6.3%,云迹(0267...
Jin Rong Jie· 2026-02-20 03:09
Core Viewpoint - The Hong Kong stock market saw a collective rise in robotics concept stocks, indicating positive investor sentiment in the sector [1] Group 1: Stock Performance - Yujian (02432.HK) experienced an 18% increase in stock price [1] - Suton Juchuang (02498.HK) rose by over 9% [1] - Ubtech (09880.HK) saw a 6.3% increase [1] - Yunjie (02670.HK) increased by 5.78% [1]
发盈喜,速腾聚创大涨超15%
Ge Long Hui· 2026-02-20 02:37
港股频道更多独家策划、专家专栏,免费查阅>> 责任编辑:安东 2月20日,智能激光雷达供应商速腾聚创(2498.HK)盘初涨幅扩大至超15%。消息面上,公司昨日发布盈利预告,预计2025年 第四季度将首次实现单季度盈利,且盈利不少于人民币6000万元,大大超出管理层此前做出的盈亏平衡预期,标志着公司 经营进入新阶段。 分析指出,此次盈利超预期,得益于公司在机器人业务领域的领先布局与技术产品优势。数据显示,2025年其机器人领域 激光雷达销量突破30.3万台,同比激增超11倍,登顶全球第一;第四季度总销量达45.96万台,其中机器人应用达22.12万 台,与ADAS业务基本持平,机器人业务已成为核心增长引擎,推动公司业务结构发生深刻变化。 ...
港股异动丨春晚机器人出圈,相关概念股集体大涨,优必选涨近9%
Ge Long Hui· 2026-02-20 02:33
Core Viewpoint - The Hong Kong stock market saw a significant rise in robotics concept stocks, driven by the showcase of humanoid robots during the Spring Festival Gala, leading to increased consumer interest and sales in related products [1][2]. Group 1: Market Performance - Robotics stocks such as Yujian surged over 18%, Suton Jichuang increased by over 11%, and Shoucheng Holdings rose by 9% [1]. - Other notable gains included Youbixuan with nearly 9%, Yunjie, Sanhua Intelligent Control, and Jizhi Jia-W each rising over 6%, while MicroPort Scientific and Lijin Technology increased by over 5% [1]. - The total market capitalization for these companies varied, with Youbixuan at 757.12 billion, and Shoucheng Holdings at 189.48 billion [2]. Group 2: Sales Growth - During the Spring Festival period from February 16 to 18, Douyin e-commerce reported a 1680% year-on-year increase in GMV for robot products, with order volume rising by 655% [1]. - The "Spring Festival Gala" effect contributed to the popularity of related products, as several emerging humanoid robot startups showcased their innovations during the event [1].
速腾聚创(02498)股价涨超15%,Q4预盈不低于6000万超预期
智通财经网· 2026-02-20 02:30
Core Viewpoint - SUTENG JUCHUANG (02498) is expected to achieve its first quarterly profit in Q4 2025, with a profit of no less than RMB 60 million, marking a significant transition in its operations and indicating that its robotics business has entered a phase of scaling up from investment [1][3]. Group 1: Financial Performance - The company anticipates a substantial shift in its profitability structure, with the Q4 2025 earnings forecast exceeding market expectations, validating the management's strategic execution [3]. - The sales of laser radar products in the robotics sector are projected to exceed 303,000 units in 2025, representing an over 1100% year-on-year increase, making the company the global market leader in this field [3]. - The total sales of laser radar in Q4 2025 are expected to reach 459,600 units, with nearly half (221,200 units) coming from the robotics sector, contributing to improved overall gross margins and profitability quality [3]. Group 2: Robotics Business Development - SUTENG JUCHUANG has established a leading position in multiple high-growth segments, including lawn mowing robots, humanoid robots, and autonomous delivery vehicles [4][5]. - The company has deep partnerships with major clients in the lawn mowing robot sector, enhancing its competitive edge [4]. - In the humanoid robot sector, SUTENG JUCHUANG has achieved the highest sales of laser radar in China, with significant collaborations with over 20 intelligent robotics companies [4]. Group 3: Market Outlook and Growth Potential - The company is well-positioned for sustainable high growth and profitability, with a substantial backlog of orders and projects set for delivery in 2026 [6]. - Favorable policies and market conditions are expected to further enhance growth opportunities, with the Chinese humanoid robot market projected to see a 133% increase in annual sales to 28,000 units by 2026 [6]. - SUTENG JUCHUANG's digital laser radar products are anticipated to meet the increasing demand from the smart automotive and robotics sectors, supported by government initiatives [6]. Group 4: Analyst Ratings and Future Projections - Daiwa Securities has reiterated a "Buy" rating for SUTENG JUCHUANG, raising the target price to HKD 60 and significantly increasing the forecast for non-ADAS laser radar shipments [7]. - Projections for laser radar shipments have been raised for 2026 from 450,000 to 746,600 units, and for 2027 from 650,000 to 1,200,000 units, indicating a positive outlook for the company's profitability and valuation [7]. - The company is positioned at a new developmental starting point with long-term growth potential in both the smart automotive and embodied intelligence sectors [7].
速腾聚创逆势高开超4%,预计首次实现单季度盈利6000万
Jin Rong Jie· 2026-02-20 02:06
Core Viewpoint - The company SUTENG JUCHUANG (2498.HK) is expected to achieve its first quarterly profit in Q4 2025, with profits projected to exceed RMB 60 million, significantly surpassing previous breakeven expectations, indicating a new phase in its operations [1] Group 1: Financial Performance - The company reported a high opening of 4.42%, reaching HKD 35.92 [1] - The anticipated profit for Q4 2025 is not less than RMB 60 million, marking a substantial improvement from earlier forecasts [1] Group 2: Business Growth - The company's success is attributed to its leading position and technological advantages in the robotics sector [1] - In 2025, laser radar sales in the robotics field are expected to exceed 303,000 units, representing a year-on-year increase of over 1100% [1] - Total sales in Q4 are projected to reach 459,600 units, with 221,200 units attributed to robotics applications, nearly equal to the ADAS business, indicating a significant shift in the company's business structure [1]
港股异动 | 速腾聚创(02498)早盘涨超11% 机器人业务增长强劲 第四季度首次单季实现盈利
智通财经网· 2026-02-20 01:48
速腾聚创表示,业绩增长主要得益于公司在机器人业务领域的相关布局与技术产品优势。公开数据显 示,2025年速腾聚创在机器人领域的激光雷达销量突破30.3万台,同比激增超11倍;第四季度激光雷达 总销量达45.96万台,其中机器人领域达22.12万台,与ADAS业务基本持平,意味着公司业务结构正发 生深刻变化。 智通财经APP获悉,速腾聚创(02498)早盘涨超11%,截至发稿,涨11.16%,报38.24港元,成交额5902.6 万港元。 消息面上,速腾聚创发布盈利预告,2025年全年净亏损同比大幅收窄,其中第四季度盈利不少于人民币 6000万元,首次实现单季度盈利,超出管理层此前做出的盈亏平衡预期。 ...
港股异动 | 机器人概念股普涨 春晚引爆机器人热潮 机构看好头部企业将开启大规模量产
智通财经网· 2026-02-20 01:41
Group 1 - The core viewpoint of the articles highlights a significant surge in robot-related stocks, driven by the popularity of robot performances during the Spring Festival Gala, leading to increased sales and interest in the sector [1][2] - Notable stock performances include Yujiang (02432) up 6.52% to 42.5 HKD, Hesai-W (02525) up 6.05% to 214 HKD, and SUTENG (02498) up 5.76% to 36.38 HKD, among others [1] - JD reported a substantial increase in robot-related metrics during the Spring Festival Gala, with search volume up over 300%, customer inquiries up 460%, and order volume up 150% within two hours of the event [1] Group 2 - Dongwu Securities emphasizes that the advancements in core robotic capabilities are crucial for the industry's transition from experimental phases to mass production, marking a significant development from 2021 to 2025 [2] - The report anticipates that by 2026, major companies like Tesla and leading domestic firms will commence large-scale production, representing a new phase in the industry [2] - Investment focus is expected to narrow down to companies with genuine mass production capabilities and integration into the supply chain [2]
港股公告掘金 | 英矽智能、图达通及长风药业获纳入恒生综合指数成份股
Zhi Tong Cai Jing· 2026-02-20 01:28
Major Events - Ying Si Intelligent (03696), Tu Datong (02665), and Changfeng Pharmaceutical (02652) have been included in the Hang Seng Composite Index [1] - Hansoh Pharmaceutical (03692) has received EU approval for the marketing of Amivantamab for monotherapy [1] - Bole Vision Cloud-B (02592) has had its clinical trial application for CBT-199 approved, recognized as safe to proceed [1] - CSPC Pharmaceutical Group (01093) has received clinical trial approval in the US for a GLP-1/GIP receptor dual agonist long-acting injection [1] - CSPC Pharmaceutical Group (01093) has also received clinical trial approval in China for Ropivacaine long-acting injection (SYH9089) [1] - Fuhong Hanlin (02696) has received FDA approval for the Phase I clinical trial application of HLX15-SC for the treatment of multiple myeloma [1] Financial Data - Shougang Resources (00639) issued a profit warning, expecting a net profit attributable to shareholders of approximately HKD 600 million to 700 million for the fiscal year 2025 [1] - Shijiazhuang Pharmaceutical Group (02005) issued a profit warning, anticipating a year-on-year decline in net profit attributable to shareholders of approximately 45% to 60% [1] - Goodbaby International (01086) issued a profit warning, expecting a year-on-year decline in net profit of approximately 35% to 45% for 2025 [1] - Suoteng Juchuang (02498) reported continued growth in sales of laser radar products for fiscal year 2025, achieving profitability for the first time in Q4 [1]
速腾聚创2025财年激光雷达产品销售持续增长 第4季度首次单季实现盈利
Xin Lang Cai Jing· 2026-02-19 23:49
Core Viewpoint - The company SUTENG JUCHUANG (02498) expects a significant reduction in net loss attributable to shareholders for 2025, projecting it to be no more than 180 million RMB, compared to an estimated net loss of approximately 481.8 million RMB for 2024 [1] Group 1 - The improvement in estimated net loss is primarily due to the continuous growth in sales of lidar products in the fiscal year 2025 [1] - The fair value gains on financial assets measured at fair value through profit or loss also contribute to the reduction in net loss [1] - The company anticipates achieving a quarterly profit of no less than 60 million RMB in the fourth quarter of fiscal year 2025 [1]
不少于6000万元 速腾聚创首次实现单季度盈利
Mei Ri Jing Ji Xin Wen· 2026-02-19 14:47
2月19日,《每日经济新闻》记者从速腾聚创(02498.HK)官方获悉,公司于2025年第四季度首次实现单 季度盈利,且盈利不少于人民币6000万元。 官方数据显示,2025年,速腾聚创机器人领域激光雷达销量突破30.3万台,同比增长超11倍。2025年第 四季度,速腾聚创总销量达45.96万台,其中机器人应用达22.12万台,与ADAS业务基本持平。 ...